Tumor-Associated Proteolytic Factors uPA and PAI-1 in Endometrial Carcinoma

Author： Kohler U.   Hiller K.   Martin R.   Langanke D.   Naumann G.   Bilek K.   Janicke F.   Schmitt M.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.66, Iss.2, 1997-08, pp. : 268-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

uPA/PAI-1 expression and uPA promoter methylation in meningiomas

By Kandenwein Julia   Park-Simon Tjoung-Won   Schramm Johannes   Simon Matthias  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 533-539

Springer Publishing Company

Access to resources Recommend Favorite

High levels of uPA and PAI-1 predict a good response to anthracyclines

By Borstnar Simona  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 615-624

Springer Publishing Company

Access to resources Recommend Favorite

High levels of uPA and PAI-1 predict a good response to anthracyclines

By Pritchard Kathleen  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 625-626

Springer Publishing Company

Access to resources Recommend Favorite

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

By Strojan P.   Budihna M.   S   mid L.   Vrhovec I.   S   krk J.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1193-1197

Elsevier

Access to resources Recommend Favorite

Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue

By Pedersen A.N.   Mouridsen H.T.   Tenney D.Y.   Brunner N.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 899-908

Elsevier

Access to resources Recommend Favorite